Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Machine Learning (2)
- (-) Materials Science (2)
- (-) Security (3)
- Artificial Intelligence (3)
- Biology (3)
- Chemical Sciences (2)
- Computer Science (4)
- Cybersecurity (4)
- Decarbonization (1)
- Energy Storage (3)
- Environment (2)
- Exascale Computing (1)
- Frontier (2)
- Grid (1)
- Materials (4)
- National Security (6)
- Neutron Science (12)
- Partnerships (1)
- Physics (3)
- Quantum Science (1)
- Space Exploration (1)
Media Contacts
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
Over the past seven years, researchers in ORNL’s Geospatial Science and Human Security Division have mapped and characterized all structures within the United States and its territories to aid FEMA in its response to disasters. This dataset provides a consistent, nationwide accounting of the buildings where people reside and work.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.